Sabine Knipp

2.0k total citations · 1 hit paper
20 papers, 1.4k citations indexed

About

Sabine Knipp is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Sabine Knipp has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 13 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Sabine Knipp's work include Acute Myeloid Leukemia Research (15 papers), Histone Deacetylase Inhibitors Research (8 papers) and Retinoids in leukemia and cellular processes (6 papers). Sabine Knipp is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Histone Deacetylase Inhibitors Research (8 papers) and Retinoids in leukemia and cellular processes (6 papers). Sabine Knipp collaborates with scholars based in Germany, Switzerland and Italy. Sabine Knipp's co-authors include Ulrich Germing, Andrea Kuendgen, Barbara Hildebrandt, Corinna Strupp, Aristoteles Giagounidis, Carlo Aul, Rainer Haas, Rosangela Invernizzi, Mario Cazzola and Matteo Giovanni Della Porta and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Sabine Knipp

20 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic Syndromes

2007 695 citations Luca Malcovati, Ulrich Germing et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Sabine Knipp

Since Specialization

Citations

This map shows the geographic impact of Sabine Knipp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Knipp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Knipp more than expected).

Fields of papers citing papers by Sabine Knipp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Knipp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Knipp. The network helps show where Sabine Knipp may publish in the future.

Co-authorship network of co-authors of Sabine Knipp

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Knipp. A scholar is included among the top collaborators of Sabine Knipp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Knipp. Sabine Knipp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement 2007 ·Leukemia Research ·Sabine Knipp, Norbert Gattermann, M Schapira, H Käferstein, Ulrich Germing	24
2	Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome 2007 ·Leukemia Research ·Sabine Knipp, Corinna Strupp, Norbert Gattermann, Barbara Hildebrandt, M Schapira, Aristoteles Giagounidis, Carlo Aul, Rainer Haas, Ulrich Germing	17
3	A pilot study of bendamustine in elderly patients with high-risk MDS and AML 2007 ·Leukemia & lymphoma ·Corinna Strupp, Sabine Knipp, Julia Hartmann, Norbert Gattermann, Rainer Haas, Ulrich Germing	8
4	Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high‐risk karyotypes 2007 ·Cancer ·Sabine Knipp, (unknown), Andrea Kündgen, Aristoteles Giagounidis, Guido Kobbe, Rainer Haas, Carlo Aul, Norbert Gattermann, Ulrich Germing	82
5	Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic Syndromes breakdown → 2007 ·Journal of Clinical Oncology ·Luca Malcovati, Ulrich Germing, Andrea Kuendgen, Matteo Giovanni Della Porta, Cristiana Pascutto, Rosangela Invernizzi, Aristoteles Giagounidis, Barbara Hildebrandt, Paolo Bernasconi, Sabine Knipp, Corinna Strupp, Mario Lazzarino, Carlo Aul, Mario Cazzola	695
6	Dependency of Survival on Additional Karyotype Anomalies and Bone Marrow Blast Count in Patients Suffering from Myelodysplastic Syndromes with 5q Deletion. 2007 ·Blood ·Sabine Knipp, Barbara Hildebrandt, Martine Jotterand, M Schapira, Aristoteles Giagounidis, Norbert Gattermann, Carlo Aul, Ulrich Germing	2
7	Exisulind induces apoptosis in advanced myelodysplastic syndrome (MDS) and acute myeloid leukaemia/MDS 2006 ·British Journal of Haematology ·Akos Czibere, Wolf Christian Prall, Luiz F. Zerbini, Markus Jäger, Guido Kobbe, Sabine Knipp, Towia A. Libermann, Rainer Haas, Manuel Aivado	11
8	Secondary myelodysplastic syndrome following long-term treatment with azathioprine in patients with multiple sclerosis 2006 ·Multiple Sclerosis Journal ·Norman Putzki, Sabine Knipp, (unknown), (unknown), Ulrich Germing, H. C. Diener, Volker Limmroth	12
9	Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes. 2006 ·PubMed ·Ulrich Germing, Corinna Strupp, Andrea Kuendgen, (unknown), Sabine Knipp, Barbara Hildebrandt, Aristoteles Giagounidis, Carlo Aul, Norbert Gattermann, Rainer Haas	95
10	The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all‐trans retinoic acid in patients with acute myeloid leukemia 2005 ·Cancer ·Andrea Kuendgen, Mathias Schmid, Richard F. Schlenk, Sabine Knipp, Barbara Hildebrandt, Christian Steidl, Ulrich Germing, Rainer Haas, Hartmut Döhner, Norbert Gattermann	188
11	Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia 2005 ·Annals of Hematology ·Andrea Kuendgen, Sabine Knipp, Frank Fox, Corinna Strupp, Barbara Hildebrandt, Christian Steidl, Ulrich Germing, Rainer Haas, Norbert Gattermann	127
12	Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes 2005 ·Blood ·Akira Matsuda, Ulrich Germing, Itsuro Jinnai, (unknown), Andrea Kuendgen, Sabine Knipp, Manuel Aivado, Masako Iwanaga, Yasushi Miyazaki, Hideki Tsushima, Mari Sakai, Masami Bessho, Masao Tomonaga	79
13	A WHO Classification-Based Prognostic Scoring System (WPSS) for Predicting Survival in Myelodysplastic Syndromes. 2005 ·Blood ·Luca Malcovati, Ulrich Germing, A. Kuendgen, Matteo Giovanni Della Porta, Rosangela Invernizzi, Aristoteles Giagounidis, Barbara Hildebrandt, Paolo Bernasconi, Sabine Knipp, Mario Lazzarino, Corinna Strupp, Mario Cazzola	21
14	Valproic Acid (VPA) Achieves High Response Rates in Patients with Low-Risk Myelodysplastic Syndromes. 2005 ·Blood ·A. Kuendgen, Mathias Schmid, Sabine Knipp, Akos Czibere, Barbara Hildebrandt, Christian Steidl, Rainer Haas, Ulrich Germing, Hartmut Doehner, Norbert Gattermann	8
15	Continued Low-Dose Decitabine (DAC) Is an Active First-Line Treatment of Older AML Patients: First Results of a Multicenter Phase II Study. 2005 ·Blood ·Michael Lübbert, Björn Rüter, Mathias Schmid, Sabine Knipp, Ulrich Germing, Christiane Dobbelstein, Hartmut Eimermacher, Barbara Deschler-Baier, Rainer Claus, Richard F. Schlenk, Arnold Ganser, Hartmut Döhner, Claudia Schmoor, H. Henß	10
16	Intensive Chemotherapy Is Not Recommended for Patients with AML or High-Risk MDS Aged over 60 Years with Complex Karyotype Anomalies. 2004 ·Blood ·Sabine Knipp, Barbara Hildebrandt, Aristoteles Giagounidis, Guido Kobbe, Rainer Haas, Carlo Aul, Norbert Gattermann, Ulrich Germing	6
17	Phase 2 Trial of the Histone Deacetylase Inhibitor Valproic Acid as a Monotherapy or in Combination with All-Trans Retinoic Acid in 24 Patients with Acute Myeloid Leukemia. 2004 ·Blood ·Andrea Kuendgen, Corinna Strupp, Barbara Hildebrandt, Sabine Knipp, (unknown), Rainer Haas, Ulrich Germing, Norbert Gattermann	2
18	Ex vivo apoptosis, CD95 and CD28 expression in T cells of children with juvenile idiopathic arthritis 2002 ·Rheumatology International ·Sabine Knipp, Oliver Feyen, (unknown), Tim Niehues	6
19	Relapsing polychondritis in childhood - case report and short review 2000 ·Rheumatology International ·Sabine Knipp, H. Bier, Gerd Horneff, Christof Specker, Antje Schuster, Horst Schroten, H. G. Lenard, Tim Niehues	19
20	Treatment-Resistant Expansion of CD8+CD28− Cells in Pediatric HIV Infection 2000 ·Pediatric Research ·Tim Niehues, Gerd Horneff, Sabine Knipp, Ortwin Adams, V. Wahn	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact